Compare CMCO & TECX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CMCO | TECX |
|---|---|---|
| Founded | 1875 | 2019 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Construction/Ag Equipment/Trucks | |
| Sector | Industrials | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 390.2M | 371.0M |
| IPO Year | 2002 | 2018 |
| Metric | CMCO | TECX |
|---|---|---|
| Price | $20.35 | $22.07 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 10 |
| Target Price | $26.75 | ★ $71.00 |
| AVG Volume (30 Days) | ★ 495.4K | 163.3K |
| Earning Date | 11-03-2026 | 11-05-2026 |
| Dividend Yield | ★ 1.38% | N/A |
| EPS Growth | N/A | ★ 40.70 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $936,240,000.00 | N/A |
| Revenue This Year | $76.00 | N/A |
| Revenue Next Year | $4.04 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 3.27 | N/A |
| 52 Week Low | $11.99 | $16.77 |
| 52 Week High | $24.40 | $39.53 |
| Indicator | CMCO | TECX |
|---|---|---|
| Relative Strength Index (RSI) | 68.73 | 51.09 |
| Support Level | $13.08 | $20.52 |
| Resistance Level | $22.29 | $23.03 |
| Average True Range (ATR) | 1.14 | 1.32 |
| MACD | 0.61 | 0.44 |
| Stochastic Oscillator | 96.74 | 77.02 |
Columbus McKinnon Corp is a world-wide designer, manufacturer and marketer of intelligent motion solutions for material handling that move the world forward and improve lives by efficiently and ergonomically moving, lifting, positioning and securing materials. Its key products include hoists, crane components, precision conveyor systems, rigging tools, light rail workstations and digital power and motion control systems. These are relevant, professional-grade solutions that solve its customers critical material handling requirements. The company has one operating and reportable segment. It has presence in United State, Germany, Europe, Middle East, and Africa (Excluding Germany), Canada, Asia Pacific, and Latin America. It has majority of sales from United States.
Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease. The company focuses on areas of important unmet medical need, often where therapeutic options are poor or nonexistent, and where new medicines have the potential to improve patient quality of life or extend duration of life. Pipeline includes TX000045, Group 2 PH, TX2100: GPCR Antagonist for Hereditary Hemorrhagic Telangiectasia (HHT), Fibrosis.